골다공증의 진단과 치료
Treatment and Diagnosis of Osteoporosis
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Osteoporosis is a skeletal disorder characterized by a compromised bone strength and an increased risk of fracture. Older women with low bone mineral density (BMD) have a higher prevalence of atherosclerotic vascular disease (coronary artery disease, ischemic stroke, or peripheral arterial disease) than older women with normal BMD. Also stroke is frequently followed by extensive bone loss, precipitating the increased fracture risk in survivors. Complications from fractures lead to increased morbidity and mortality. In this paper, the clinical evidence, diagnosis and treatments of osteoporosis will be reviewed.
Abstract
Osteoporosis is a skeletal disorder characterized by a compromised bone strength and an increased risk of fracture. Older women with low bone mineral density (BMD) have a higher prevalence of atherosclerotic vascular disease (coronary artery disease, ischemic stroke, or peripheral arterial disease) than older women with normal BMD. Also stroke is frequently followed by extensive bone loss, precipitating the increased fracture risk in survivors. Complications from fractures lead to increased morbidity and mortality. In this paper, the clinical evidence, diagnosis and treatments of osteoporosis will be reviewed.
참고문헌 (15)
- "Osteoporosis Fact Sheet 2014"[URL]
- Korean Society for bone and Mineral Research, "Physician’s guide for diagnosis and treatment of osteoporosis 2015", 1~166 (2015)
- Cosman F, "National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis", Osteoporos Int, 25, pp.2359~2381 (2014)
- Myint PK, "Bone mineral density and incidence of stroke: European prospective investigation into cancer-norfolk population-based study, systematic review, and meta-analysis", Stroke, 45, pp.373~382 (2014)
- Carda S, "Osteoporosis after stroke: a review of the causes and potential treatments", Cerebrovasc Dis, 28, pp.191~200 (2009)
- Minn YK, "Osteoporosis as an independent risk factor for silent brain infarction and white matter changes in men and women:the PRESENT project.", Osteoporos Int, 25, pp.2465~2369 (2014)
- Cummings SR, "Risk and prevention of fracture in patients with major medical illnesses: a mini-review", J Bone Miner Res, 31, pp.2069~2072 (2016)
- Gage BF, "Risk of osteoporotic fracture in elderly patients taking warfarin: results from the national registry of atrial fibrillation 2", Arch Intern Med, 23, pp.241~246 (2006)
- Harvey NC, "Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice", Bone, 78, pp.216~224 (2015)
- Bolland MJ, "Calcium supplements increase risk of myocardial infarction", J Bone Miner Res, 30, pp.389~390 (2015)
- Francis RM, "National osteoporosis society practical clinical guideline on vitamin D and bone health", Maturitas, 80, pp.119~121 (2015)
- Bilezikian JP, "Parathyroid hormone as an anabolic therapy for women and men", J Endocrinol Invest, 28(8 Suppl), pp.41~49 (2005)
- Austin M, "Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures", J Bone Miner Res, 27, pp.687~693 (2012)
- Barrett-Connor E, "Raloxifene use for the heart (RUTH) trial investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women", N Engl J Med, 355, pp.125~137 (2006)
- Miller PD, "Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study", J Bone Miner Res, 23, pp.525~535 (2008)